Antimalarial evaluation of selected medicinal plant extracts used in Iranian traditional medicine

Document Type: Original Article


1 Infectious and Tropical Diseases Research Center, Health Research Institute Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Leishmaniasis Disease Registry Committee, Dezful University of Medical Sciences, Dezful, Iran

3 Department of Parasitology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

4 Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran

5 Zanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran


Objective(s): In an attempt to discover new natural active extracts against malaria parasites, the present study evaluated the antiplasmodial properties of selected plants based on Iranian traditional medicine.
Materials and Methods: Ten plant species found in Iran were selected and collected based on the available literature about the Iranian traditional medicine. The methanolic extracts of these plants were investigated for in vitro antimalarial properties against chloroquine-sensitive (3D7) and multi-drug resistant (K1) strains of Plasmodium falciparum. Their in vivo activity against Plasmodium berghei infection in mice was also determined. Cytotoxicity tests were carried out using the Raji cells line using the MTT assay. The extracts were phytochemically screened for their active constituents.
Results: According to the IC50 and selectivity index (SI) values, of the 10 selected plant species, Citrullus colocynthis, Physalis alkekengi, and Solanum nigrum displayed potent in vitro antimalarial activity against both 3D7 and K1 strains with no toxicity (IC50= 2.01-18.67 µg/ml and SI=3.55 to 19.25).  Comparisons between treated and untreated control mice showed that the mentioned plant species reduced parasitemia by 65.08%, 57.97%, and 60.68%, respectively.  The existence of antiplasmodial compounds was detected in these plant extracts.
Conclusion: This was the first study to highlight the in vitro and in vivo antiplasmodial effects of             C. colocynthis, P. alkekengi, and S. nigrum in Iran. Future studies can use these findings to design further biological tests to identify the active constituents of the mentioned plant species and clarify their mechanism of action.


1.World Health Organization. World malaria report 2010. Availabe at: http:// malaria/world-malaria-report-2010/en/.

2. World Health Organization. World malaria report 2015. Geneva 2015. Availabe at: http://

3. Sargolzaie N, Salehi M, Kiani M, Sakeni M, Hasanzehi A. Malaria epidemiology in Sistan and Balouchestan province during April 2008-March 2011, Iran Zahedan. J Resh Med Sci 2011; 16: 41-43.

4.  World Health Organization . Iran Malaria Profile. World Malaria Report 2005. Geneva: WHO; 2005.

5. World Health Organization.World malaria report 2011. Geneva 2011. Availabe at: http://

6. Maregesi S1, Van Miert S, Pannecouque C, Feiz Haddad MH, Hermans N, Wright CW, Vlietinck AJ, Apers S, Pieters L. Screening of Tanzanian medicinal plants against Plasmodium falciparum and human immunodeficiency virus. Planta Med 2010; 76: 195-201.

7. World Health Organization. Guidelines for the treatment of malaria: World Health Organization; 2006.

8. Raeisi A, Gouya MM, Nadim A, Ranjbar M, Hasanzehi A, Fallahnezhad M, et al. Determination of malaria epidemiological status in Iran, s malarious areas as baseline information for implemention of malaria elimination program in Iran. Iran J Publ Health 2013; 42:326-333.

9. World Health Organization. The use of antimalarial drugs, part II: Artemisinin and its derivatives 2001.

10. Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop 2005; 95:305-315.

11.  Heravi M. Alabnya an al-Haghayegh al-Advia. Tehran, Iran: Tehran University;1992.

12.  Jorjani L. Zakireh Kharazmshahi. Tehran: Bonyade Farhang Iran; 1992.

13. Khorasani A. Makhzan ol-Advieh. Tehran: Enghelab e Eslami Publishing and Educational Organization; 1992.

14. Zargari A.  Medical plants. Tehran: Tehran University; 2003.

15. Ibn Sina. Al Qanun Fi al-Tibb.Persian translated by Sharafkandi A. Tehran, Iran: Soroush Press; 2005.

16. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193:673-675.

17. Dagger F, Valdivieso E, Marcano AK, Ayesta C. Regulatory volume decrease in Leishmania mexicana: effect of anti-microtubule drugs. Mem Inst Oswaldo Cruz 2013; 108:84-90.

18. Chakrabarti R, Rawat PS, Caoke BM, Coppel RL, Patankar S. Cellular effects of Curcumin on Plasmodium falciparum include disruption of microtubules. PLoS One 2013; 8:e57302.

19. Lambros C, Vanderberg JP. Synchronization of  plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979; 65:418-420.

20. Sangian H, Faramarzi H, Yazdinezhad A, Mousavi SJ, Zamani Z, Noubarani M, et al.  Antiplasmodial activity of ethanolic extract of some selected medicinal plants from the northwest of Iran. Parasitol Res 2013; 112:3697-3701.

21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J  Immunol Methods 1983; 65:55-63.

22. Peters W. The chemotherapy of rodent malaria, XXII. The value of drug resistant strains of P. berghei in screening for blood schizontocidal activity. Ann Trop Med Parasitol 1975; 69:155-171.

23. Peters W, Robinson BL. The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. Ann Trop Med Parasitol 1992; 86:455-465.

24. Evans WC. Treace and evans pharmacognosy. 14th ed. London: Bailiere Tindall W.B. Saunders;1996.

25. Farnsworth NR. Biological and phytochemical screening of plants. J Pharm Sci 1966; 55: 225-276.

26. George NJ, Ikot AN, Obi-Egbedi NO. Phytochemical and antimicrobial properties of leaves of Alchonea cordifolia. Eur J Chem 2010; 7:1071-1079.

27. Kumar GG, Gali V. Phytochemical screening of Abutilon muticum (del. ex dc.) and Celosia argentea Linn. Int J Pharm Biol Sic 2011; 2:463-467.

28. Malebo HM, Tanja W, Cal M, Swaleh SA, Omdo MO, Hassanali A. Antiplasmodial, anti trypanosomal, anti leishmanial and cytotoxicity activity of selected Tanzanian medical plants. Tanzan J Health Res 2009; 11:226-234.

29. Sarr S, Perrotey S, Fall I, Ennahar S, Zhao M, Diop YM, Candolfi E, Marchioni E. Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity. Malar J  2011; 10:85.

30. Philippe G, Angenot L, Mol PD, Goffin E, Hayette MP, Tits M, Fredrich M. In vitro screening of some Strychnos species for antiplasmodial activity. J Ethnopharmacol 2005; 97: 535-539. 

31. Pink R, Hudson A, Mouries MA, Bending M. Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov 2005; 4:727-740.

32. Jonville MC, Kodja H, Humeau L, De Mol P, Cao M, Angenot L, Frédérich M. Screening of medicinal plants from Reunion Island for antimalarial and cytotoxic activity. J Ethnopharmacol 2008; 120:382–386.

33. Rani P, Khullar N. Antimicrobial evaluation of some medicinal plants for their anti enteric potential against multi drug resistant Salmonella typhi. Phytother Res 2004; 18:670-673.

34. Acharya E, Pokhrel B. Ethno-medicinal plants used by Bantar of Bhaudaha, Morang, Nepal. Our Nat 2006; 4: 96-103. 

35. Zakaria ZA, Gopalan HK, Zainal H, Mohd Pojan NH, Morsid NA, Aris A, Sulaiman MR .Antinociceptive, anti-inflammatory and antipyretic effects of Solanum nigrum chloroform extract in animal models. Yakugaku Zasshi 2006; 126:1171-1178.

36. Mans DR, Beerens T, Magali I, Soekhoe RC, Schoone GJ, Oedairadjsingh K, et al. In vitro evaluation of traditionally used Surinamese medicinal plants for their potential anti-leishmanial efficacy. J Ethnopharmacol 2016; 180:70-77.

37. Saddiqe Z, Maimoona A, Khalid S. Phytochemical analysis and anthelmintic activity of extracts of aerial part of Solanum nigrum L. Biologia 2013; 59:205-211.

38. Hammami H, Ayadi A. Molluscicidal and antiparasitic activity of Solanum nigrum Villosum against Galba truncatula infected or uninfected with Fasciola hepatica. J Helmintol 2008; 82: 235-239.

39. Batista R, De Jesus Silvanior A, De Oliveira AB. Plant-derived antimalarial agents: new leads and efficient phytomedicines. Part II. Non-alkaloidal natural products. Molecules 2009; 14: 3037-3072.

40. Gogoi P, Islam M. Phytochemical screening of Solanum nigrum L  and S.myriacanthus Dunal from districts of upper Assam, India. IOSR J Pharmacy 2012; 2: 455-459.

41. Ghosh D. Tannins from food to combat diseases. Int J Pharm Res Rev 2015; 4:40-44.

42. Hsieh WT, Huang KY, Lin HY, Chung JG. Physalis anagulata induced G2/M phase arrest in human breast cancer cells. Food ChemToxicol 2006; 44:974-983.

43. Lusakibanza M, Mesia G, Tona G, Karemere S, Lukuka A, Tits M, et al. In vitro and in vivo antimalarial and cytotoxic activity of five plants used in Congolese traditional medicine. J Ethnopharmacol 2010; 129:398-402.

44. Ruiz L, Maco M, Cobos M, Gutierrez-Choquevilca Aa-L, Roumy V. Plants used by native Amazonian groups from the Nanay River (Peru) for the treatment of malaria. J Ethnopharmacol 2011; 133:917-921.

45. Rengifo Salgado E, Vargas Arana G. Physalis angulata L.(Bolsa Mullaca): a review of its traditional uses, chemistry and pharmacology. Bol latinoam Caribe Plant Med Aromat 2013; 12:431-45.

46. Sa MS, de Menezes MN, Krettli AU, Ribeiro IM, Tomassini TC, Ribeiro dos Santos R, et al. Antimalarial activity of Physalis B, D, F and G. J Nat Prod 2011; 74:2269-2272.

47. AAN A, Al-rahwi K, Lindequist U. Some medicinal plants used in Yemeni herbal medicinal to treat malaria. Afr J Tradit Complement Altern Med/2004; 1:72-76.

48. Meena MC, Meena RK, Patni V. Ethanobotanical studies of Citrullus colocynthis ( Linn.) Schrad. An important threatened medicinal herb. J Med Plants Stud 2014; 2:15-22.

49. Tonkaboni M. Tohfeh al-Momenin. Tehran: Shahid Beheshti University of Medical Sciences; 2007.

50. Marzouk B, Marzouk Z, Fenina N, Bouraoui A, Aouni M. Anti-inflammatory and analgesic activities of Tunisian Citrullus colocynthis Schrad. immature fruit and seed organic extracts. Eur Rev Med Pharmacol Sci 2011; 15:665-672.

51.  Marzouk B, Marzouk Z, Dcor R, Edziri H, Haloui E,

Fenina N, Aouni M. Antibacterial and anticandidal screening of Tunisian Citrullus colocynthis Schrad. from Medenine. J Ethnopharmacol 2009; 125:344-349.

52. Saeed BQ, Hassan HF, Arteen HI. Effect of some medical plant extracts on metabolism of Leishmania tropica promastigotes In vitro. J Med Microb Diagn 2014; 3:165.

53. Ahmed Hassan LE, Sirat HM, Yagil SMA, Koko WS, Abdelwahab SI. In vitro antimicrobial activities of chloroformic, hexane and ethanolic extracts of Citrullus lanatus var. Citroides (wild melon). J Med Plants Res 2011; 5:1338-1344.

54. Onyeibor O, Croft SL, Dodson HI, Feiz-Haddad M H, Kendrick H, Millington NJ, Parapini S, Phillips RM, Seville S, Shnyder SD, Taramelli D, Wright CW. Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action. J Med Chem. 2005; 7; 2701-9.